Search
for

    Sort by

    Research 301–330 of 1000+

    1. The preventive and therapeutic efficacy of finasteride and dutasteride in TRAMP mice The FASEB Journal · 2013
    2. Impact of a Novel Dehydroepiandrosterone Derivative on the Metabolism of RWPE-1 and LNCaP Cell Lines Oriental Journal Of Chemistry · 2026
    3. The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis World Journal of Urology · 2026
    4. Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model European Urology Focus · 2026
    5. Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review International Journal of Social health · 2025
    6. MP11-05 THE UROLOGIC IMPACT OF LONG-TERM FINASTERIDE-1 MG USE FOR ANDROGENIC ALOPECIA: A MATCHED-COHORT DATABASE ANALYSIS The Journal of Urology · 2025
    7. Thiohydrazides in the Synthesis of Functionalized Extranuclear Heterosteroids 2023
    8. Potential Pharmacological Activities of Pumpkin Seeds as a Functional Food: A Comprehensive Review Journal of Ayurvedic and herbal medicine · 2023
    9. Synthesis of novel andostane-N-cyclohexyl-17-carboxamides, and their effect on the 5α-reductase isoform 2, the androgen receptor, and androgen-dependent glands Pharmaceutical Sciences · 2021
    10. Decision letter: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization 2020
    11. MP44-04 TRENDS IN 5-ALPHA REDUCTASE INHIBITOR USE BEFORE AND AFTER THE FOOD AND DRUG ADMINISTRATION SAFETY WARNING 2019
    12. Review: Adding α<sub>1</sub>-blockers to 5α-reductase inhibitors improves lower urinary tract symptoms in men Annals of Internal Medicine · 2014
    13. 1262 ONE YEAR FINASTERIDE THERAPY IN MEN WITH A SERUM PSA GREATER THAN 4 NG/ML WHO HAD UNDERGONE REPEAT BIOPSY The Journal of Urology · 2012
    14. A cornerstone of hematological science Community oncology · 2012
    15. Provenge is Talk of GU Malignancies Congress Oncology Times · 2010
    16. UP-02.28 Urology · 2006
    17. Editorial comment 1 Urology · 2004
    18. Latent hazard in PC and BPH patients referred to antiandrogens:PC aggressiveness and NE differentiation Anticancer Research · 2004
    19. 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione Acta Crystallographica Section C-crystal Structure Communications · 1998
    20. Synthesis, Characterization and Evaluation of 5α, 6β-Dihalo Androsterone Derivatives as 5α-Reductase Inhibitors Current Enzyme Inhibition · 2022
    21. Finasteride Elsevier eBooks · 2015
    22. PD16-01 NEW INSIGHT OF PSA REDUCTION DURING FINASTERIDE THERAPY The Journal of Urology · 2015
    23. Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition Endocrine Reviews · 2005 · 451 citations
    24. Molecular basis of androgen insensitivity Molecular and Cellular Endocrinology · 2001 · 309 citations
    25. Sex differences in COVID-19: the role of androgens in disease severity and progression Endocrine · 2020 · 121 citations
    26. Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy Integrative Cancer Therapies · 2010 · 61 citations
    27. Cardiovascular Toxicities of Androgen Deprivation Therapy Current Treatment Options in Oncology · 2021 · 45 citations
    28. Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride The Journal of Steroid Biochemistry and Molecular Biology · 2012 · 45 citations
    29. Does a male polycystic ovarian syndrome equivalent exist? Journal of Endocrinological Investigation · 2017 · 28 citations
    30. Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease Endocrine Related Cancer · 2019 · 25 citations